Baldwin Wealth Partners LLC MA decreased its position in Colgate-Palmolive (NYSE:CL – Free Report) by 9.4% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 2,317 shares of the company’s stock after selling 240 shares during the quarter. Baldwin Wealth Partners LLC MA’s holdings in Colgate-Palmolive were worth $211,000 as of its most recent SEC filing.
A number of other institutional investors have also made changes to their positions in the company. Union Bancaire Privee UBP SA bought a new stake in Colgate-Palmolive during the fourth quarter valued at $32,000. Reston Wealth Management LLC bought a new stake in shares of Colgate-Palmolive during the 3rd quarter valued at about $42,000. Capital Performance Advisors LLP acquired a new stake in Colgate-Palmolive during the third quarter worth about $53,000. Prospera Private Wealth LLC bought a new position in Colgate-Palmolive in the third quarter worth about $64,000. Finally, True Wealth Design LLC lifted its holdings in Colgate-Palmolive by 1,460.9% in the third quarter. True Wealth Design LLC now owns 718 shares of the company’s stock worth $75,000 after acquiring an additional 672 shares during the last quarter. 80.41% of the stock is currently owned by institutional investors.
Colgate-Palmolive Price Performance
NYSE:CL opened at $91.19 on Tuesday. Colgate-Palmolive has a 52-week low of $82.68 and a 52-week high of $109.30. The company has a quick ratio of 0.68, a current ratio of 1.04 and a debt-to-equity ratio of 9.46. The firm has a market cap of $74.50 billion, a P/E ratio of 26.13, a PEG ratio of 3.59 and a beta of 0.44. The business’s 50-day moving average price is $91.81 and its 200 day moving average price is $97.45.
Colgate-Palmolive Dividend Announcement
Insider Buying and Selling
In other news, CFO Stanley J. Sutula III sold 45,410 shares of the business’s stock in a transaction on Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the sale, the chief financial officer now directly owns 36,726 shares of the company’s stock, valued at $3,456,283.86. The trade was a 55.29 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 0.34% of the stock is currently owned by insiders.
Analyst Ratings Changes
A number of brokerages have recently weighed in on CL. Barclays dropped their price target on Colgate-Palmolive from $96.00 to $83.00 and set an “equal weight” rating on the stock in a research report on Friday, January 17th. Stifel Nicolaus cut their target price on Colgate-Palmolive from $101.00 to $95.00 and set a “hold” rating on the stock in a research note on Friday, January 17th. StockNews.com lowered shares of Colgate-Palmolive from a “buy” rating to a “hold” rating in a research report on Thursday, January 9th. TD Cowen cut their price objective on shares of Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating on the stock in a research report on Wednesday, January 8th. Finally, UBS Group reduced their target price on shares of Colgate-Palmolive from $112.00 to $104.00 and set a “buy” rating for the company in a research note on Thursday, January 16th. One analyst has rated the stock with a sell rating, ten have issued a hold rating and twelve have given a buy rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus price target of $101.11.
Get Our Latest Stock Analysis on Colgate-Palmolive
Colgate-Palmolive Company Profile
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Recommended Stories
- Five stocks we like better than Colgate-Palmolive
- Investing in Commodities: What Are They? How to Invest in Them
- Sizing Up a New Opportunity for NVIDIA Investors
- Why Invest in High-Yield Dividend Stocks?
- Is DeepSeek Challenging NVIDIA’s AI Dominance?
- Do ETFs Pay Dividends? What You Need to Know
- The 3 Biggest M&A Stock Opportunities for 2025
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.